FENC
Fennec Pharmaceuticals Inc
10.20$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,525.5% | -34.8% | +276.4% | +62.6% | -31.8% | -41.7% | +3.8% | -64.8% | -86.3% | +619.4% | -10.7% | -55.8% | -25.9% | +35.4% | -57.0% | +289.8% | +615.0% | -19.2% | -38.4% | +122.1% | -28.7% | +20.2% | -0.3% | +67.3% | +55.9% | |
| – | +2,179.4% | -37.8% | -46.1% | +550.4% | -38.2% | -56.0% | +180.9% | -66.0% | -85.2% | +619.4% | -10.7% | -55.8% | -25.9% | +35.4% | -57.0% | +289.8% | +615.0% | -19.2% | -39.5% | +126.3% | -28.7% | +19.4% | +0.5% | +64.3% | +50.9% | |
| – | +8,315.4% | -97.8% | +939.1% | +535.5% | -12.5% | -52.7% | +185.3% | -66.9% | -87.2% | +768.2% | -10.9% | -56.5% | -27.8% | +38.7% | -59.2% | +316.8% | +619.8% | -19.4% | -40.1% | +122.3% | -30.5% | +12.7% | -44.2% | +100.7% | +37.9% | |
| – | +8,315.4% | -40.4% | -61.4% | +866.0% | -36.8% | -56.9% | +185.3% | -66.9% | -87.2% | +768.2% | -10.9% | -56.5% | -27.8% | +38.7% | -59.2% | +316.8% | +619.8% | -19.4% | -40.1% | +122.3% | -30.5% | +12.7% | -44.2% | +100.7% | +37.9% | |
| – | +364.0% | -0.1% | -83.9% | +1,114.2% | -46.7% | -28.5% | +79.6% | -24.9% | -50.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | +470.5% | +46.2% | +79.9% | |
| – | – | – | +30.5% | -54.1% | -61.0% | +59.3% | +96.8% | -33.5% | -39.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | +274.3% | -50.8% | +47.4% | |
| – | +150.7% | +21.8% | -23.2% | -13.5% | -11.1% | -21.7% | -2.7% | -52.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -9.7% | -27.8% | -29.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.5% | +15.8% | +1,306.0% | -15.6% | -3.9% | +7.3% | -66.0% | -1.8% | -85.8% | +2,456.7% | -49.9% | +33.8% | -56.2% | -45.2% | -73.2% | -14.6% | +309.0% | -0.4% | +38.7% | +3.3% | +183.0% | +344.3% | +30.4% | +32.0% | -31.1% | |
| – | +9.5% | +32.1% | +56.7% | +35.6% | +80.6% | +76.2% | -48.8% | +1.2% | -82.7% | +2,499.3% | -49.9% | +33.8% | -56.2% | -45.2% | -73.2% | -14.6% | +309.0% | -0.4% | +38.7% | +3.3% | -29.5% | +178.7% | +63.9% | -8.4% | +51.7% | |
| – | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -53.9% | -93.8% | -59.8% | +406.1% | – | – | – | – | – | – | -90.5% | – | |
| – | +44.0% | +63.7% | +41.8% | +21.1% | -22.5% | +49.7% | -74.3% | +2.8% | -41.9% | -14.5% | +25.7% | -24.3% | -18.1% | +45.3% | -3.6% | -17.8% | +250.4% | +20.7% | +56.2% | -2.5% | -50.5% | +207.6% | +58.1% | -14.2% | +42.8% | |
| – | -74.1% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +399.2% | +24.2% | -37.5% | – | |
| – | +20,913.0% | -38.1% | +151.8% | +115.6% | -39.2% | -62.2% | +86.5% | -78.4% | -86.7% | -1,312.8% | – | – | – | – | -10.6% | +551.5% | +649.5% | -20.3% | -44.3% | +144.8% | -45.7% | -116.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13.1% | +58.5% | -67.8% | +87.6% | +155.2% | +0.0% | +88.5% | +10.0% | +0.0% | +130.3% | +13.3% | +4.6% | +26.1% | -6.6% | +9.7% | +17.9% | +17.6% | +26.7% | +4.6% | +19.1% | +9.7% | +1.0% | +1.1% | +2.7% | +4.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.